Literature DB >> 9660473

Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure.

A Schubach1, M C Marzochi, T Cuzzi-Maya, A V Oliveira, M L Araujo, A L Oliveira, R S Pacheco, H Momen, F Conceicao-Silva, S G Coutinho, K B Marzochi.   

Abstract

Two former patients treated for the cutaneous form of American tegumentary leishmaniasis were reviewed eight and 11 years, respectively, following clinical cure. We were able to isolate Leishmania parasites in a culture of material from the two scar biopsies, and in one of them the parasite was characterized as Leishmania (Viannia) braziliensis. In both cases, the histopathology revealed discreet hyperceratosis and a slight infiltrate of mononuclear cells surrounding and on the walls of the surface and deep dermal vessels. No amastigotes were seen on immunohistochemical or histopathologic examination. The Montenegro skin test result and the in vitro lymphoproliferative response to Leishmania antigen were positive, but no specific IgG and IgM antibodies were detected. Otorhinolaryngologic examination showed no macroscopic alteration in the mucosae. These findings are important for the evaluation and criteria of post-treatment cure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660473     DOI: 10.4269/ajtmh.1998.58.824

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  28 in total

1.  Endemic tegumentary leishmaniasis in Brazil: correlation between level of endemicity and number of cases of mucosal disease.

Authors:  Sandro J Bedoya-Pacheco; Maria H Araujo-Melo; Claudia M Valete-Rosalino; Maria Inês F Pimentel; Fátima Conceição-Silva; Armando O Schubach; Mauro C A Marzochi
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Quantitative Kinetoplast DNA Assessment During Treatment of Mucosal Leishmaniasis as a Potential Biomarker of Outcome: A Pilot Study.

Authors:  Marlene Jara; Braulio Mark Valencia; Vanessa Adaui; Milena Alba; Rachel Lau; Jorge Arevalo; Alejandro Llanos-Cuentas; Andrea K Boggild
Journal:  Am J Trop Med Hyg       Date:  2015-10-19       Impact factor: 2.345

3.  Up-regulation of Th1-type responses in mucosal leishmaniasis patients.

Authors:  Olívia Bacellar; Hélio Lessa; Albert Schriefer; Paulo Machado; Amélia Ribeiro de Jesus; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species.

Authors:  Yira Rosalba Díaz; Ricardo Rojas; Liliana Valderrama; Nancy Gore Saravia
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

5.  Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.

Authors:  Tiago M Castilho; Karen Goldsmith-Pestana; Caterin Lozano; Liliana Valderrama; Nancy G Saravia; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

6.  Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis.

Authors:  Ibeth Romero; Jair Téllez; Yazmín Suárez; Maria Cardona; Roger Figueroa; Adrian Zelazny; Nancy Gore Saravia
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14

7.  Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006).

Authors:  Erica de Camargo Ferreira E Vasconcellos; Maria Inês Fernandes Pimentel; Armando de Oliveira Schubach; Raquel de Vasconcellos Carvalhaes de Oliveira; Rilza Beatriz Azeredo-Coutinho; Fátima da Conceição Silva; Mariza de Matos Salgueiro; João Soares Moreira; Maria de Fátima Madeira; Cibele Baptista; Cláudia Maria Valete-Rosalino
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

8.  Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia).

Authors:  María Adelaida Gómez; Adriana Navas; Miguel Dario Prieto; Lina Giraldo-Parra; Alexandra Cossio; Neal Alexander; Nancy Gore Saravia
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 9.079

9.  Canine Cutaneous Leishmaniasis: Dissemination and Tissue Tropism of Genetically Distinct Leishmania (Viannia) braziliensis Populations.

Authors:  Guilherme Marx de Oliveira; Maria de Fátima Madeira; Fernanda Santos Oliveira; Marize Quinhones Pires; Raquel da Silva Pacheco
Journal:  Vet Med Int       Date:  2013-06-12

10.  Occupationally acquired american cutaneous leishmaniasis.

Authors:  Maria Edileuza Felinto de Brito; Maria Sandra Andrade; Ericka Lima de Almeida; Angela Cristina Rapela Medeiros; Roberto Pereira Werkhäuser; Ana Isabele Freitas de Araújo; Sinval Pinto Brandão-Filho; Alzira Maria Paiva de Almeida; Eduardo Henrique Gomes Rodrigues
Journal:  Case Rep Dermatol Med       Date:  2012-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.